-
The Washington, DC-based National Abortion Federation (NAF) has launched the first interactive on-line continuing medical education (CME) program to allow health care providers to learn more about mifepristone.
-
Your next patient, a 19-year-old woman who is sexually active, says she douches on a weekly basis for hygiene purposes. She has been previously treated for a sexually transmitted disease (STD). What should you tell her?
-
Review the number of patients who came through your examination room today, and count how many were screened for one or more sexually transmitted diseases (STDs). If the answer is zero, then perhaps it is time to review your practice guidelines.
-
Who should not use Essure?
-
American women now have a choice when it comes to permanent birth control: They can opt to undergo tubal ligation or choose the Essure transcervical sterilization procedure.
-
Your patient is a young mother in a mutually monogamous relationship who cannot tolerate oral contraceptives, has heavy menses, and says she doesnt want to use an injectable birth control method. She has no medical insurance coverage. What options can you offer her?
-
Since about one-fourth of all U.S. women ages 15-44 who have ever married have undergone tubal sterilization,1 chances are that you have counseled women about their permanent contraceptive options.
-
You reviewed the instructions for initiating the first pack of oral contraceptives (OCs) with your patient. She elects to use the Sunday start, beginning pills on the first Sunday after her next period. When she returns for a follow-up visit in a few months, though, you discover she never started the pills and now is pregnant.
-
-
In this pooled analysis of more than 7700 ovarian cancer patients and nearly 12,000 controls, low-dose aspirin and high-dose non-aspirin NSAID use was associated with a risk reduction for invasive epithelial ovarian cancer of 20-34% relative to non-users. Acetaminophen use was not associated with a risk reduction, irrespective of dose or frequency.